4//SEC Filing
McClung David 4
Accession 0001437749-25-037474
CIK 0000925741other
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 9:54 PM ET
Size
8.9 KB
Accession
0001437749-25-037474
Insider Transaction Report
Form 4
BioCardia, Inc.BCDA
McClung David
Chief Financial Officer
Transactions
- Award
Common Stock
2025-12-08$1.37/sh+58,276$79,838→ 106,226 total - Tax Payment
Common Stock
2025-12-08$1.37/sh+29,339$40,194→ 76,887 total - Award
Stock Option (right to buy)
2025-12-08+27,000→ 46,340 totalExercise: $1.37Exp: 2035-12-08→ Common stock (20,000 underlying)
Footnotes (3)
- [F1]The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock awarded as compensation in lieu of cash. 100% of the RSUs vested on December 8, 2025.
- [F2]The reported securities represent the shares that have been withheld by the Issuer to satisfy its income tax, withholding and remittance obligations in connection with the net settlement of the RSUs vested on December 8, 2025 and does not represent a sale by the Reporting Person.
- [F3]The option vests and becomes exercisable as to 1/48th of the shares on January 8, 2026, and each month thereafter, subject to the Reporting Person continuing as a service provider through such date.
Documents
Issuer
BioCardia, Inc.
CIK 0000925741
Entity typeother
Related Parties
1- filerCIK 0001686155
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 9:54 PM ET
- Size
- 8.9 KB